Last update Date/Time:
EU RESPONSE TO COVID-19
Research & Innovation
COMBACTE-NET - Combatting bacterial resistance in Europe (NL)
This Innovative Medicines Initiative (IMI) project is dedicated to building strong clinical, laboratory and research networks across Europe.
Stemming from the Antarex project, EXCALATE operates the Italian Supercomputer in CINECA.
The platform is analysing COVID-19 proteins based on data available from the scientific community in order to accelerate the search of an effective therapy. A new project – Exscalate4CoV. (E4C) invites collaboration to screen potential drugs.
INNOVATIVE MEDICINES INITIATIVE
Fighting-off Coronavirus (SARS-CoV-2) with broad-spectrum antivirals: establishing animal challenge model, that will prepare the way towards broad-spectrum antiviral treatments that can be taken intranasally.
Monoclonal Antibodies against 2019 New Coronavirus.
• Testimonial from Franck Grosveld (Cell biologist at Harbour Antibodies, Rotterdam)
• Futuris video: Europe supercharges research in the battle against COVID-19
Rapid interaction profiling of 2019-nCoV for network-based deep drug repurpose learning (DDRL).
Swift COronavirus therapeutics Response. The project aims to develop of combination anti-viral treatments for patients infected with the coronavirus.
Exploration of safety, tolerability and clinical efficacy of Solnatide IMP in patients infected with the 2019 new coronavirus.
The SynBio4Flav platform is using synthetic biology to provide a cost-effective alternative to current flavonoid production.
Antibody therapy against coronavirus (COVID-2019).
Another example of using the power of supercomputers is the BioExcel project.
Nanobodies and antibodies against 2019-nCoV. The project aims to rapidly identify, validate and produce antibodies that block the ability of the virus to infect cells, for treatment and prevention in humans.